Quarterly results round-up: Abbott staying conservatively optimistic, Quest and St Jude see profits fall
This article was originally published in Clinica
Abbott is "setting up well for 2012" with guidance for the year ahead "largely encouraging", according to Morgan Stanley analyst David Lewis. The firm is predicting earnings of $4.95-5.05 for full-year 2012, within Wall Street consensus expectations of $5.02. Mr Lewis described Abbott's approach as "healthy conservatism".